U.S. researchers found that injecting the IL-22 molecule in normal mice stimulated genes that spur the development of psoriasis-like skin lesions -- a finding that suggests the molecule could offer a new way to treat the chronic skin disease. Researchers also found that antibodies that neutralize the molecule inhibited the development of the disease in mice.

Related Summaries